82 FR 26112 - National Institute of General Medical Sciences; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 107 (June 6, 2017)

Page Range		26112-26112
FR Document		2017-11599

Federal Register, Volume 82 Issue 107 (Tuesday, June 6, 2017)

[Federal Register Volume 82, Number 107 (Tuesday, June 6, 2017)]
[Notices]
[Page 26112]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-11599]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; Conference Grant Review.
    Date: July 7, 2017.
    Time: 2:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, Room 
3An.12N, 45 Center Drive, Bethesda, MD 20892 (Telephone Conference 
Call).
    Contact Person: Lee Warren Slice, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Institute of General 
Medical Sciences, National Institutes of Health, 1 Democracy Plaza, 
6701 Democracy Blvd. Room 1068, Bethesda, MD 20892, 301-435-0807, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives; 93.859, Biomedical Research and 
Research Training, National Institutes of Health, HHS)


    Dated: May 31, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-11599 Filed 6-5-17; 8:45 am]
 BILLING CODE 4140-01-P

26112 Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices

DEPARTMENT OF HEALTH AND Extramural Policy and Review, Division of DEPARTMENT OF HEALTH AND
HUMAN SERVICES Extramural Research, National Institute on HUMAN SERVICES
Drug Abuse, NIH, DHHS, 6001 Executive
National Institutes of Health Boulevard, Room 4242, MSC 9550, Bethesda,
National Institutes of Health
MD 20892, 301–827–5833, ivan.navarro@
National Institute on Drug Abuse; nih.gov.
National Institute of General Medical
Notice of Closed Meetings (Catalogue of Federal Domestic Assistance
Sciences; Notice of Closed Meeting
Program Nos.: 93.279, Drug Abuse and
Pursuant to section 10(d) of the Addiction Research Programs, National
Federal Advisory Committee Act, as Institutes of Health, HHS) Pursuant to section 10(d) of the
amended (5 U.S.C. App), notice is Federal Advisory Committee Act, as
Dated: May 31, 2017.
hereby given of the following meetings. amended (5 U.S.C. App.), notice is
Natasha M. Copeland, hereby given of the following meeting.
The meetings will be closed to the
Program Analyst, Office of Federal Advisory
public in accordance with the The meeting will be closed to the
Committee Policy.
provisions set forth in sections public in accordance with the
[FR Doc. 2017–11593 Filed 6–5–17; 8:45 am]
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., provisions set forth in sections
as amended. The grant applications and BILLING CODE 4140–01–P
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
the discussions could disclose as amended. The grant applications and
confidential trade secrets or commercial the discussions could disclose
DEPARTMENT OF HEALTH AND
property such as patentable material, confidential trade secrets or commercial
HUMAN SERVICES
and personal information concerning
property such as patentable material,
individuals associated with the grant National Institutes of Health and personal information concerning
applications, the disclosure of which
would constitute a clearly unwarranted individuals associated with the grant
National Institute on Drug Abuse;
invasion of personal privacy. applications, the disclosure of which
Notice of Closed Meeting
would constitute a clearly unwarranted
Name of Committee: National Institute on
Pursuant to section 10(d) of the invasion of personal privacy.
Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00). Federal Advisory Committee Act, as Name of Committee: National Institute of
Date: June 13, 2017. amended (5 U.S.C. App), notice is General Medical Sciences Special Emphasis
Time: 1:00 p.m. to 5:00 p.m. hereby given of the following meeting. Panel; Conference Grant Review.
Agenda: To review and evaluate grant The meeting will be closed to the Date: July 7, 2017.
applications.
Place: National Institutes of Health,
public in accordance with the Time: 2:00 p.m. to 3:00 p.m.
Neuroscience Center, 6001 Executive provisions set forth in sections Agenda: To review and evaluate grant
Boulevard, Rockville, MD 20852 (Telephone 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications.
Conference Call). as amended. The contract proposals and Place: National Institutes of Health,
Contact Person: Susan O. McGuire, Ph.D., the discussions could disclose Natcher Building, Room 3An.12N, 45 Center
Scientific Review Officer, Office of confidential trade secrets or commercial Drive, Bethesda, MD 20892 (Telephone
Extramural Policy and Review, National property such as patentable material, Conference Call).
Institute on Drug Abuse, National Institutes and personal information concerning Contact Person: Lee Warren Slice, Ph.D.,
of Health, DHHS, 6001 Executive Blvd., Scientific Review Officer, Office of Scientific
Room 4245, Rockville, MD 20852, (301) 827– individuals associated with the contract
proposals, the disclosure of which Review, National Institute of General Medical
5817, mcguireso@mail.nih.gov.
would constitute a clearly unwarranted Sciences, National Institutes of Health, 1
Name of Committee: National Institute on
invasion of personal privacy. Democracy Plaza, 6701 Democracy Blvd.
Drug Abuse Special Emphasis Panel;
Optimizing the HIV Care Continuum for Room 1068, Bethesda, MD 20892, 301–435–
Name of Committee: National Institute on
Substance Abusing Populations at High-Risk 0807, slicelw@mail.nih.gov.
Drug Abuse Special Emphasis Panel; NIDA
and/or Living with HIV (R01). Blending Initiative (2248). (Catalogue of Federal Domestic Assistance
Date: June 27, 2017. Date: June 27, 2017. Program Nos. 93.375, Minority Biomedical
Time: 11:00 a.m. to 2:00 p.m. Time: 11:00 a.m. to 12:00 p.m. Research Support; 93.821, Cell Biology and
Agenda: To review and evaluate grant Agenda: To review and evaluate contract Biophysics Research; 93.859, Pharmacology,
applications. proposals. Physiology, and Biological Chemistry
Place: National Institutes of Health, Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Research; 93.862, Genetics and
Neuroscience Center, 6001 Executive Developmental Biology Research; 93.88,
Boulevard, Rockville, MD 20852 (Telephone
Boulevard, Rockville, MD 20852 (Telephone Minority Access to Research Careers; 93.96,
Conference Call).
Conference Call).
Contact Person: Hiromi Ono, Ph.D., Special Minority Initiatives; 93.859,
Contact Person: Lyle Furr, Scientific
Scientific Review Officer, Office of Biomedical Research and Research Training,
Review Officer, Office of Extramural Affairs,
Extramural Policy and Review, National National Institutes of Health, HHS)
National Institute on Drug Abuse, NIH,
Institute on Drug Abuse, National Institutes
DHHS, Room 4227, MSC 9550, 6001
of Health, DHHS, 6001 Executive Boulevard, Dated: May 31, 2017.
Executive Boulevard, Bethesda, MD 20892–
Room 4238, MSC 9550, Bethesda, MD 20892,
9550, (301) 827–5702, lf33c.nih.gov. David Clary,
301–827–5820, hiromi.ono@nih.gov.
Name of Committee: National Institute on (Catalogue of Federal Domestic Assistance Program Analyst, Office of Federal Advisory
Drug Abuse Special Emphasis Panel; Program No.: 93.279, Drug Abuse and Committee Policy.
Medications Development. Addiction Research Programs, National [FR Doc. 2017–11599 Filed 6–5–17; 8:45 am]
mstockstill on DSK30JT082PROD with NOTICES

Date: July 13, 2017. Institutes of Health, HHS)
BILLING CODE 4140–01–P
Time: 9:00 a.m. 5:00 p.m. Dated: May 31, 2017.
Agenda: To review and evaluate Natasha M. Copeland,
cooperative agreement applications.
Program Analyst, Office of Federal Advisory
Place: Hilton Garden Inn Bethesda, 7301
Committee Policy.
Waverly Street, Bethesda, MD 20814.
Contact Person: Ivan K. Navarro, Ph.D., [FR Doc. 2017–11594 Filed 6–5–17; 8:45 am]
Scientific Review Officer, Office of BILLING CODE 4140–01–P

VerDate Sep<11>2014 20:52 Jun 05, 2017 Jkt 241001 PO 00000 Frm 00071 Fmt 4703 Sfmt 9990 E:\FR\FM\06JNN1.SGM 06JNN1

Document Created: 2017-06-06 06:21:21
Document Modified: 2017-06-06 06:21:21

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 7, 2017.
FR Citation		82 FR 26112

82 FR 26112 - National Institute of General Medical Sciences; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 107 (June 6, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health